Regular Article
Orexins Suppress Catecholamine Synthesis and Secretion in Cultured PC12 Cells

https://doi.org/10.1006/bbrc.2000.3137Get rights and content

Abstract

New orexigenic peptides called orexin-A and -B have recently been described in neurons of the lateral hypothalamus and perifornical area. No orexins have been found in adipose tissues or visceral organs, including the adrenal gland. However, expression of the orexin-receptor 2 (OX2R) in the rat adrenal gland has been reported. To test the effects of orexins on peripheral organs, we investigated their effects on catecholamine synthesis and secretion in the rat pheochromocytoma cell line PC12. Orexin-A and -B (100 nM) significantly reduced basal and PACAP-induced tyrosine hydroxylase (TH) (the rate-limiting enzyme in the biosynthesis of catecholamines) mRNA levels. Orexin-A and -B (100 nM) also significantly inhibited the PACAP-induced increase in the cAMP level, suggesting that the suppressive effect on TH mRNA is mediated, at least in part, by the cAMP/protein kinase A pathway. Furthermore, orexin-A and -B (100 nM) significantly suppressed basal and PACAP-induced dopamine secretion from PC12 cells. Next, we examined whether orexin receptors (OX1R, OX2R) were present in the rat adrenal gland and PC12 cells. In the adrenal glands, OX2R was as strongly expressed as in the hypothalamus, but OX1R was not detected. On the other hand, neither OX1R nor OX2R was expressed in PC12 cells. However, binding assays showed equal binding of orexin-A and -B to PC12 cells, suggesting the existence in these cells of some receptors for orexins. These results indicate that orexins suppress catecholamine release and synthesis, and that the inhibitory effect is mediated by the cAMP/protein kinase A pathway.

References (26)

  • T. Nambu et al.

    Brain Res. Inter.

    (1999)
  • P. Trivedi et al.

    FEBS Lett.

    (1998)
  • M.K. Stachowiak et al.

    J. Biol. Chem.

    (1990)
  • B. Hiremagalur et al.

    J. Biol. Chem.

    (1993)
  • M.F. Czyzyk-Krzeska et al.

    J. Biol. Chem.

    (1994)
  • K. Isobe et al.

    Neuropeptides

    (1996)
  • W.K. Samson et al.

    Brain Res.

    (1999)
  • K. Takekoshi et al.

    Biochem. Biophys. Res. Commun.

    (1999)
  • R.M. Chemelli et al.

    Cell

    (1999)
  • L. Lin et al.

    Cell

    (1999)
  • Y. Yamamoto et al.

    Mol. Brain Res.

    (1999)
  • T. Sakurai et al.

    Cell

    (1999)
  • Cited by (48)

    • OX2R activation induces PKC-mediated ERK and CREB phosphorylation

      2012, Experimental Cell Research
      Citation Excerpt :

      Orexins had different effects on cAMP in different type of sources. Orexins may not stimulate cAMP accumulation [34] or inhibit the PACAP-induced increase in the cAMP level in PC12 cells [37]. Conversely, orexin significantly increased the cAMP level in human adrencortical cells [38].

    • Role of PACAP in the physiology and pathology of the sympathoadrenal system

      2008, Frontiers in Neuroendocrinology
      Citation Excerpt :

      PACAP stimulates the gene transcription of catecholamine biosynthetic enzymes in PC12 cells. The neuropeptide activates PAC1 receptors to increase TH gene transcription through a PKA-controlled pathway [18,19,101], and induces PNMT gene expression through activation of cAMP-PKA and extracellular Ca2+ signaling mechanisms [170]. In addition, PACAP regulates the gene transcription of chromogranins; the peptide enhances CgA and CgB gene expression [44,86,144], and inhibits SgII gene expression [44].

    View all citing articles on Scopus
    View full text